Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking (NCT05679349) | Clinical Trial Compass
RecruitingNot Applicable
Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking
United States822 participantsStarted 2024-04-01
Plain-language summary
This clinical trial tests how well providing education improves screening for lung cancer in patients with a history of smoking. Screenings may help doctors find lung cancer sooner when it may be easier to treat. Education and counseling may be an effective method to help providers and patients learn about lung cancer screening. Providing education and decision counseling to providers and patients may increase lung cancer screening.
Who can participate
Age range
50 Years – 77 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* PRACTICE LEVEL:
* Primary care practice (family medicine, geriatrics, internal medicine) in one of the 4 participating health systems
* Practice using the main electronic medical record (EMR) of each system, in order to run appropriate patient recruitment reports
* Practice with at least 50% of practice providers (physicians and advanced care providers) consenting to participate
* PATIENT LEVEL:
* Have an office or telemedicine established patient visit scheduled with a primary care provider in one of the participating practices within next 14 to 25 days
* 50 to 77 years of age
* Have at least a 20-pack-year smoking history (based on self-report at baseline eligibility assessment)
* Currently smoke or have quit smoking within the past 15 years (based on self-report at baseline eligibility assessment)
* Able to communicate in English or Spanish (determined at baseline eligibility assessment)
Exclusion Criteria:
* PATIENT OUTREACH:
* Any lung computed tomography (CT) or low-dose computed tomography (LDCT) scan in the past 11 months, current procedural terminology (CPT) Codes are as follows
* G0297 - LDCT screening
* 71250 - CT w/o contrast
* 71260 - CT w/ contrast
* 71270 - CT with and w/o contrast
* 71275 - CT angiography chest
* 78815 - Positron emission tomography computed tomography (PET CT) skull base to mid-thigh
* 78816 - PET CT whole body
* Prior history of lung cancer (The patient's problem list includes a problem with an interna…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Given that this study focuses on outreach and support to help people actually complete their first lung cancer screening, would my doctor's office or care team be involved in the support activities, and how might that affect my regular care?
2Since this trial is measuring whether people complete their initial lung cancer screening rather than testing a new medical treatment, does that mean the main 'intervention' here is things like reminders or counseling rather than a new drug or procedure, and what exactly would I be asked to do as a participant?
3I have a history of smoking — does my doctor think I already meet the standard criteria for lung cancer screening with a low-dose CT scan, and if so, should I just get screened now through my regular insurance coverage rather than waiting to see if this trial is a good fit for me?
4Because this trial is listed as 'Phase NA,' it seems more like a study of how to improve access to screening rather than a clinical drug trial — can my doctor help me understand what risks, if any, are actually involved in participating, and whether there are any downsides compared to getting screened outside the study?
5If I do join this study and complete my initial lung cancer screening, what happens next — does the trial include any follow-up support or care if something is found on the scan, or would I be on my own to navigate next steps?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.